SCM
Silvant Capital Management Portfolio holdings
AUM
$2.64B
This Quarter Return
+18.49%
1 Year Return
+33.93%
3 Year Return
+193.12%
5 Year Return
+278.91%
10 Year Return
–
AUM
$1.78B
AUM Growth
+$1.78B
(+16%)
Cap. Flow
+$2.4M
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
52.41%
Holding
310
New
14
Increased
56
Reduced
56
Closed
5
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$52.3M |
| 2 |
West Pharmaceutical
WST
|
$4.17M |
| 3 |
Adobe
ADBE
|
$4.09M |
| 4 |
Rockwell Automation
ROK
|
$4M |
| 5 |
Apple
AAPL
|
$3.25M |
Top Sells
| 1 |
Estee Lauder
EL
|
$37M |
| 2 |
NVIDIA
NVDA
|
$11.5M |
| 3 |
Amazon
AMZN
|
$7.58M |
| 4 |
EPAM Systems
EPAM
|
$6.47M |
| 5 |
Public Storage
PSA
|
$5.33M |
Sector Composition
| 1 | Technology | 43.59% |
| 2 | Healthcare | 15.9% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Communication Services | 9.34% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Prologis
PLD
$103B
| $2.46M | 0.14% |
20,067
-8
| -0% | -$981 |
|
102
Enphase Energy
ENPH
$4.85B
| $2.43M | 0.14% |
14,525
-3,432
| -19% | -$575K |
|
103
Five Below
FIVE
$8.33B
| $2.36M | 0.13% |
12,011
-9,676
| -45% | -$1.9M |
|
104
Inspire Medical Systems
INSP
$2.53B
| $2.27M | 0.13% |
7,000
| – | – |
|
105
CVS Health
CVS
$93B
| $2.24M | 0.13% |
32,400
-13
| -0% | -$899 |
|
106
LPL Financial
LPLA
$28.5B
| $2.22M | 0.13% |
10,224
| – | – |
|
107
Deere & Co
DE
$127B
| $2.14M | 0.12% |
5,275
+311
| +6% | +$126K |
|
108
Veeva Systems
VEEV
$44.4B
| $2.05M | 0.12% |
+10,373
| New | +$2.05M |
|
109
HCA Healthcare
HCA
$95.4B
| $1.98M | 0.11% |
6,537
-2
| -0% | -$607 |
|
110
McKesson
MCK
$85.9B
| $1.97M | 0.11% |
4,607
+1,189
| +35% | +$509K |
|
111
Abbott
ABT
$230B
| $1.96M | 0.11% |
17,989
+10,736
| +148% | +$1.17M |
|
112
Stryker
SYK
$149B
| $1.9M | 0.11% |
+6,206
| New | +$1.9M |
|
113
Belden
BDC
$5.03B
| $1.88M | 0.11% |
19,607
| – | – |
|
114
Bentley Systems
BSY
$16.2B
| $1.85M | 0.1% |
+34,084
| New | +$1.85M |
|
115
Sarepta Therapeutics
SRPT
$1.98B
| $1.81M | 0.1% |
15,838
-8,096
| -34% | -$927K |
|
116
Zimmer Biomet
ZBH
$20.8B
| $1.81M | 0.1% |
+12,378
| New | +$1.81M |
|
117
DoubleVerify
DV
$2.61B
| $1.79M | 0.1% |
+46,068
| New | +$1.79M |
|
118
CME Group
CME
$97.1B
| $1.79M | 0.1% |
9,645
-4
| -0% | -$741 |
|
119
Neurocrine Biosciences
NBIX
$13.5B
| $1.73M | 0.1% |
18,294
| – | – |
|
120
IBM
IBM
$227B
| $1.68M | 0.09% |
12,569
-6
| -0% | -$803 |
|
121
Northrop Grumman
NOC
$83.2B
| $1.63M | 0.09% |
3,573
-2
| -0.1% | -$912 |
|
122
Wells Fargo
WFC
$258B
| $1.62M | 0.09% |
37,903
-11,610
| -23% | -$496K |
|
123
PPG Industries
PPG
$24.6B
| $1.61M | 0.09% |
10,835
-4
| -0% | -$593 |
|
124
Exact Sciences
EXAS
$9.33B
| $1.6M | 0.09% |
17,083
+1,123
| +7% | +$105K |
|
125
GE Aerospace
GE
$293B
| $1.59M | 0.09% |
18,167
+1,077
| +6% | +$94.4K |
|